Search clinical trials for: US-approved Neulasta

Total 1072 results

Pfizer

Completed

A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers

Healthy Volunteers

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants

Neutropenia

Australia
Intas Pharmaceuticals, Ltd.
Lambda Therapeutic Research Ltd.

Completed

Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Pharmacokinetic Bioequivalence Study in Human Healthy Volunteers

India
Intas Pharmaceuticals, Ltd.
Lambda Therapeutic Research Ltd.

Completed

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Healthy Volunteers | Immunogenicity

India
Qilu Pharmaceutical Co., Ltd.

Unknown

A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects

Healthy

Germany, United Kingdom
Fresenius Kabi SwissBioSim GmbH

Completed

Safety and Immunogenicity of MSB11455 in Healthy Participants

Healthy

New Zealand
Fresenius Kabi SwissBioSim GmbH

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

Healthy

New Zealand
Kamada, Ltd.

Completed

Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects (KAMRAB-003)

Rabies

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Celltrion

Completed

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Healthy Subjects

New Zealand
Eli Lilly and Company

Completed

A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants

Healthy

Singapore
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Healthy Subjects

Healthy Subjects
Mylan Inc.
Mylan GmbH

Completed

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Healthy Volunteers

Netherlands
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects

Healthy

Korea, Republic of
Pfizer

Completed

A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.

Healthy Volunteers

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Coherus Biosciences, Inc.

Completed

Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®

Immunity, Humoral

United States
Gan and Lee Pharmaceuticals, USA

Completed

PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males

Diabetes Mellitus

Germany
Dartmouth-Hitchcock Medical Center

Terminated

Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies

Hematologic Malignancies

United States
Sandoz
Sandoz GmbH

Completed

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim (PROTECT2)

Breast Cancer | Chemotherapy-induced Neutropenia

Spain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation
Omega Ophthalmics

Completed

Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL (ORCV)

Cataract

Costa Rica
Catharina Ziekenhuis Eindhoven
Eindhoven University of Technology

Unknown

3D US Guided Femoral Artery Access for TAVI (3D-US-TAVI)

Ultrasound Therapy; Complications | Femoral Artery Injury

Netherlands
Cinfa Biotech

Completed

Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects

Clinical Pharmacology

Germany
University Hospital, Clermont-Ferrand
Amgen

Unknown

Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5) (MEG-5)

Solid Malignancies

France
Amgen

Completed

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Non-Small Cell Lung Cancer
EVIVE Biotechnology

Completed

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Breast Cancer | Neutropenia

United States
Batterjee Medical College

Not yet recruiting

Effect of Phonophoresis on Trigger Points

Trigger Point Pain, Myofascial
Zhejiang Teruisi Pharmaceutical Inc.

Completed

A Study to Compare Pharmacokinetic and Safety of TRS003 to China-approved Bevacizumab and US-licensed Avastin®

Healthy

United States
University of Wisconsin, Madison
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)

Tumor, Solid

United States
British Columbia Children's Hospital
University of British Columbia

Unknown

Automatic Characterization of the Neonatal Hip Using Ultrasound Imaging

Developmental Dysplasia of the Hip

Canada
University Hospital Inselspital, Berne

Completed

Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis (BERNUTIFUL)

Venous Thrombosis | Postthrombotic Syndrome

Switzerland
Cinfa Biotech

Completed

Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects

Healthy Volunteers

Germany
Amgen

Completed

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Breast Cancer | Non-Hodgkin's Lymphoma | Ovarian Cancer | Lung Cancer | Neutropenia
Seno Medical Instruments Inc.

Completed

The PIONEER-01 Study of the Imagio Breast Imaging System

Breast Cancer

United States
Coherus Biosciences, Inc.

Completed

Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta

Healthy

United States
Coherus Biosciences, Inc.

Completed

Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)

Bioequivalence

United States
Huntridge Family Clinic

Unknown

What Happens in Vegas: PEP to PrEP Opportunities

Exposure to Human Immunodeficiency Virus (Event)

United States
Omega Ophthalmics

Active, not recruiting

Clinical Investigation of Omega Refractive Capsule, Model VI (ORCVI)

Cataract

Costa Rica
Celltrion

Completed

To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Healthy

Korea, Republic of
Rabin Medical Center

Unknown

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

Prostate Biopsy

Israel
Adocia

Completed

A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

Lymphoma | Myeloma Multiple

Mexico
Fresenius Kabi SwissBioSim GmbH

Completed

Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy Subjects

Healthy

Australia
Seoul National University Hospital
Green Cross Corporation

Completed

Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor (GCPGC)

Healthy

Korea, Republic of
UConn Health
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Completed

Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring

Breast Cancer

United States
Benha University

Completed

Placental Vasculature for Prediction of Recurrent Fetal Growth Restriction

Obstetric Complication
Kashiv BioSciences, LLC

Completed

To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects

Healthy

India
Celltrion

Completed

To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects

Healthy

Australia
Gedeon Richter Plc.

Completed

Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta

Bioequivalence

United Kingdom
Universidad Rey Juan Carlos

Withdrawn

US-guided Percutaneous Electrolysis (EPE®) in Plantar Fasciosis

Plantar Heel Pain, Plantar Fasciosis

Spain

3

Subscribe